Nilotinib bests imatinib in chronic myeloid leukemiaQuestions about tolerability and cost of treatment need answering before clinical practice should change Mystery miscarriages not helped by anticoagulationTrial debunks treatment that has become popular for unexplained fetal loss despite lack of evidence Caution eases over using antivirals for pandemic H1N1 Chemo- trastuzumab combo ups survival Fish oil fends off psychosis in high-risk patients Oral drugs may hold new hope for MS patients Ease of use is attractive, but questions remain over what longer-term use will show about side-effects Radial approach lessens kidney risk: B.C. study Doing cardiac catheterization through the wrist has advantages over femoral access, although it is more technically challenging Vyvanse for ADHD Negation exemptions needed for focused-practice visits, says OMA head Study finds no difference in adjuvant therapy strategies Continuous aromatase inhibitor therapy no better than starting with tamoxifen First Previous 1171 1172 1173 1174 1175 Next Last
